These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23644893)

  • 1. Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro.
    Cantley MD; Rainsford KD; Haynes DR
    Inflammopharmacology; 2013 Dec; 21(6):407-12. PubMed ID: 23644893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly.
    Yu M; Moreno JL; Stains JP; Keegan AD
    J Biol Chem; 2009 Nov; 284(47):32968-79. PubMed ID: 19801646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of receptor activator of nuclear factor (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteoclast formation and activity.
    Kreja L; Liedert A; Schmidt C; Claes L; Ignatius A
    J Mol Histol; 2007 Aug; 38(4):341-5. PubMed ID: 17576525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
    Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
    Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro.
    Cantley MD; Fairlie DP; Bartold PM; Rainsford KD; Le GT; Lucke AJ; Holding CA; Haynes DR
    J Cell Physiol; 2011 Dec; 226(12):3233-41. PubMed ID: 21344383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine dentine organic matrix down-regulates osteoclast activity.
    Sriarj W; Aoki K; Ohya K; Takagi Y; Shimokawa H
    J Bone Miner Metab; 2009; 27(3):315-23. PubMed ID: 19296049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
    Weir EC; Lowik CW; Paliwal I; Insogna KL
    J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A(2A) receptor ligation inhibits osteoclast formation.
    Mediero A; Kara FM; Wilder T; Cronstein BN
    Am J Pathol; 2012 Feb; 180(2):775-86. PubMed ID: 22138579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multinucleated giant cells with an osteoclast phenotype derived from caprine peripheral blood mononuclear cells.
    Pisoni G; D'Amelio P; Sassi F; Manarolla G; Scaccabarozzi L; Locatelli C; Mazzocchi N; Baruscotti M; DiFrancesco D; Moroni P
    Vet J; 2011 Sep; 189(3):361-3. PubMed ID: 20822938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.
    Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL
    J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human osteoclast formation and activity on a xenogenous bone mineral.
    Perrotti V; Nicholls BM; Horton MA; Piattelli A
    J Biomed Mater Res A; 2009 Jul; 90(1):238-46. PubMed ID: 18496862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
    J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an in vitro culture method for stepwise differentiation of mouse embryonic stem cells and induced pluripotent stem cells into mature osteoclasts.
    Nishikawa K; Iwamoto Y; Ishii M
    J Bone Miner Metab; 2014 May; 32(3):331-6. PubMed ID: 24366621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.
    Tsurukai T; Udagawa N; Matsuzaki K; Takahashi N; Suda T
    J Bone Miner Metab; 2000; 18(4):177-84. PubMed ID: 10874596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
    Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H
    Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.
    Kogawa M; Hisatake K; Atkins GJ; Findlay DM; Enoki Y; Sato T; Gray PC; Kanesaki-Yatsuka Y; Anderson PH; Wada S; Kato N; Fukuda A; Katayama S; Tsujimoto M; Yoda T; Suda T; Okazaki Y; Matsumoto M
    J Biol Chem; 2013 Oct; 288(43):31299-312. PubMed ID: 23990468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.